CN103920017A - Medicine composition for treating cervicitis - Google Patents
Medicine composition for treating cervicitis Download PDFInfo
- Publication number
- CN103920017A CN103920017A CN201410195831.9A CN201410195831A CN103920017A CN 103920017 A CN103920017 A CN 103920017A CN 201410195831 A CN201410195831 A CN 201410195831A CN 103920017 A CN103920017 A CN 103920017A
- Authority
- CN
- China
- Prior art keywords
- parts
- treatment
- cervicitis
- herba
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010008323 cervicitis Diseases 0.000 title claims abstract description 31
- 208000006374 Uterine Cervicitis Diseases 0.000 title claims abstract description 29
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 229940079593 drug Drugs 0.000 title claims abstract description 11
- 239000000203 mixture Substances 0.000 title claims abstract description 11
- 238000011282 treatment Methods 0.000 claims abstract description 45
- 235000009926 Dioscorea panthaica Nutrition 0.000 claims abstract description 13
- 241000374766 Dioscorea panthaica Species 0.000 claims abstract description 13
- 241000218176 Corydalis Species 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 241001078983 Tetradium ruticarpum Species 0.000 claims abstract description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 25
- 239000000706 filtrate Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 241000628997 Flos Species 0.000 claims description 12
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 12
- 239000012467 final product Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 241000437896 Corydalis bungeana Species 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 7
- 230000035876 healing Effects 0.000 abstract description 6
- 238000000554 physical therapy Methods 0.000 abstract description 3
- 210000003679 cervix uteri Anatomy 0.000 abstract description 2
- 230000005906 menstruation Effects 0.000 abstract description 2
- 230000001568 sexual effect Effects 0.000 abstract description 2
- 208000032544 Cicatrix Diseases 0.000 abstract 1
- 241001523681 Dendrobium Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241000717671 Glechoma longituba Species 0.000 abstract 1
- 235000000100 Hibiscus rosa sinensis Nutrition 0.000 abstract 1
- 241000244355 Ligusticum Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000000664 Rosa chinensis Nutrition 0.000 abstract 1
- 240000008254 Rosa chinensis Species 0.000 abstract 1
- 235000016785 Rosa della China Nutrition 0.000 abstract 1
- 210000003608 fece Anatomy 0.000 abstract 1
- 231100000241 scar Toxicity 0.000 abstract 1
- 230000037387 scars Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 5
- 238000011084 recovery Methods 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 201000003988 chronic cervicitis Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 239000008921 jie er yin Substances 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 206010065019 Coital bleeding Diseases 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000011276 addition treatment Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses medicine composition for treating cervicitis. The medicine composition is prepared from raw materials with the following weight ratio: 7 parts to 15 parts of poria cocos, 10 parts to 19 parts of fructus lycii, 3 parts to 8 parts of dioscorea panthaica prain et burkill, 12 parts to 18 parts of herba corydalis bungeanae, 15 parts to 20 parts of glechoma longituba, 15 parts to 20 parts of herba saussureae involucratae, 20 parts to 40 parts of China roses, 8 parts to 15 parts of dendrobium, 15 parts to 20 parts of teasel roots, 15 parts to 25 parts of ligusticum, and 10 parts to 14 parts of evodia rutaecarpa. By the adoption of the medicine composition for treating the cervicitis, the course of treatment is short, healing time is short, effectiveness of treatment is significant, the effusion of the excreta caused by the adoption of other physiotherapies can be avoided, sexual life can be resumed after medication is stopped till the next menstruation, patients can accept easily, according to the follow-up interview, the healed cervix is soft, good in elasticity, free of scars and free of side effects.
Description
Technical field
The invention belongs to technical field of Chinese medicines, particularly relate to a kind of pharmaceutical composition for the treatment of cervicitis.
Background technology
Various gynecological inflammations are that sickness rate is the highest in all gynaecopathias, wherein, chronic cervicitis is exactly modal frequently-occurring disease, show that according to clinical related data most women suffers from gynecological inflammation, about 70% women once suffered from chronic cervicitis and repeatedly outbreak be difficult for curing and with symptoms such as soreness of waist and knee, weak all over, refreshing lathers, gynecological inflammation repeatedly shows effect and even also causes generation serious threat women's health and the life of other pathological changes.
Gynaecopathia become be hidden in women's body a killer, be also the most obscure in the world disease, mostly because of do not note menstrual period and puerperal health or sexual life is unclean causes.This sick method for the treatment of has physiotherapy and pharmacotherapy at present, and physiotherapy is not easy operation and damages larger.Western medicine takes effect than comparatively fast, but treatment is not thorough, easily recurrence after drug withdrawal.Chinese medicine, taking oral as main, takes effect slow, and curative effect is unsatisfactory.
Summary of the invention
For above-mentioned the deficiencies in the prior art, the object of this invention is to provide a kind of pharmaceutical composition for the treatment of cervicitis, this courses of pharmaceuticals is short, and healing time is fast, after curing, is difficult for recurrence.
For realizing above-mentioned technical purpose, the present invention is achieved by the following technical solutions:
A kind of pharmaceutical composition for the treatment of cervicitis, it is to be made up of the raw material of following weight portion proportioning: Poria 7-15 part, Fructus Lycii 10-19 part, Dioscorea panthaica Prain et Burkill 3-8 part, Herba Corydalis Bungeanae 12-18 part, Glechota longituba (Nakai) Kupr 15-20 part, Herba Saussureae Involueratae 15-20 part, Flos Rosae Chinensis 20-40 part, Herba Dendrobii 8-15 part, Radix Dipsaci 15-20 part, Rhizoma Ligustici 15-25 part, Fructus Evodiae 10-14 part.
Preferably, a kind of pharmaceutical composition for the treatment of cervicitis, it is to be made up of the raw material of following weight portion proportioning: Poria 9-13 part, Fructus Lycii 15-18 part, Dioscorea panthaica Prain et Burkill 5-7 part, Herba Corydalis Bungeanae 14-17 part, Glechota longituba (Nakai) Kupr 17-19 part, Herba Saussureae Involueratae 16-18 part, Flos Rosae Chinensis 25-35 part, Herba Dendrobii 10-13 part, Radix Dipsaci 16-18 part, Rhizoma Ligustici 19-23 part, Fructus Evodiae 10-12 part.
Preferably, a kind of pharmaceutical composition for the treatment of cervicitis, it is to be made up of the raw material of following weight portion proportioning: 10 parts, Poria, 15 parts of Fructus Lycii, 5 parts of Dioscorea panthaica Prain et Burkill, 15 parts of Herba Corydalis Bungeanaes, 18 parts of Glechota longituba (Nakai) Kupr, 18 parts of Herba Saussureae Involuerataes, 30 parts of Flos Rosae Chinensiss, 13 parts of Herba Dendrobiis, 18 parts of Radix Dipsacis, 20 parts of Rhizoma Ligusticis, 12 parts of Fructus Evodiaes.
Preferably, a kind of pharmaceutical composition for the treatment of cervicitis, it is to be made up of the raw material of following weight portion proportioning: 12 parts, Poria, 17 parts of Fructus Lycii, 6 parts of Dioscorea panthaica Prain et Burkill, 16 parts of Herba Corydalis Bungeanaes, 18 parts of Glechota longituba (Nakai) Kupr, 17 parts of Herba Saussureae Involuerataes, 28 parts of Flos Rosae Chinensiss, 12 parts of Herba Dendrobiis, 17 parts of Radix Dipsacis, 21 parts of Rhizoma Ligusticis, 11 parts of Fructus Evodiaes.
The preparation method of the pharmaceutical composition of described treatment cervicitis is: get each crude drug, mix, add 8-10 and doubly measure (weight multiple) water, decoct 1-2 hour, filter to get filtrate, to the water that adds again 4-6 in medicinal residues and doubly measure (weight multiple), decoct 1-1.5 hour, filter to get filtrate, merge filtrate twice, routine concentrating under reduced pressure, the dry fine powder that to obtain, make tablet or capsule, to obtain final product.
The using method of the pharmaceutical composition for the treatment of cervicitis: when use, take out the pharmaceutical composition of a treatment cervicitis, be dissolved in 300-800mL warm water, after medicine fully dissolves, rinse affected part, once a day.
Preferably, when use, take out the pharmaceutical composition of a treatment cervicitis, be dissolved in 500mL warm water, after medicine fully dissolves, rinse affected part, once a day.
Beneficial effect of the present invention:
Short treating period, healing time is fast, evident in efficacy; The secretions that can avoid other naturopathy to cause oozes out, and after drug withdrawal is clean to next menstruation, is restorability life, and patient is acceptant; Soft through following up a case by regular visits to the cervix uteri matter of healing, good springiness, has no side effect without cicatrix.
Detailed description of the invention
Below in conjunction with embodiment and clinical data, the present invention is further illustrated.
Embodiment 1
Prepare a kind of pharmaceutical composition for the treatment of cervicitis, filling a prescription is: Poria 12g, Fructus Lycii 17g, Dioscorea panthaica Prain et Burkill 6g, Herba Corydalis Bungeanae 16g, Glechota longituba (Nakai) Kupr 18g, Herba Saussureae Involueratae 17g, Flos Rosae Chinensis 28g, Herba Dendrobii 12g, Radix Dipsaci 17g, Rhizoma Ligustici 21g, Fructus Evodiae 11g.
Preparation method is: get each crude drug, mix, add 9 times of water gagings, decocts 1.5 hours, filter to get filtrate, to the water that adds again 5 times of amounts in medicinal residues, decoct 1 hour, filter to get filtrate, merge twice filtrate, conventional concentrating under reduced pressure, be dried and obtain fine powder, make capsule, to obtain final product.
Embodiment 2
Prepare a kind of pharmaceutical composition for the treatment of cervicitis, filling a prescription is: Poria 12g, Fructus Lycii 17g, Dioscorea panthaica Prain et Burkill 6g, Herba Corydalis Bungeanae 16g, Glechota longituba (Nakai) Kupr 18g, Herba Saussureae Involueratae 17g, Flos Rosae Chinensis 28g, Herba Dendrobii 12g, Radix Dipsaci 17g, Rhizoma Ligustici 21g, Fructus Evodiae 11g.
Preparation method is: get each crude drug, mix, add 8 times of water gagings, decocts 2 hours, filter to get filtrate, to the water that adds again 6 times of amounts in medicinal residues, decoct 1.5 hours, filter to get filtrate, merge twice filtrate, concentrating under reduced pressure, be dried and obtain fine powder, make tablet, to obtain final product.
Embodiment 3
Prepare a kind of pharmaceutical composition for the treatment of cervicitis, filling a prescription is: Poria 7g, Fructus Lycii 10g, Dioscorea panthaica Prain et Burkill 3g, Herba Corydalis Bungeanae 12g, Glechota longituba (Nakai) Kupr 15g, Herba Saussureae Involueratae 15g, Flos Rosae Chinensis 20g, Herba Dendrobii 8g, Radix Dipsaci 15g, Rhizoma Ligustici 15g, Fructus Evodiae 10g.
Preparation method is: get each crude drug, mix, add 10 times of water gagings, decocts 1 hour, filter to get filtrate, to the water that adds again 4 times of amounts in medicinal residues, decoct 1 hour, filter to get filtrate, merge twice filtrate, concentrating under reduced pressure, be dried and obtain fine powder, make tablet, to obtain final product.
Embodiment 4
Prepare a kind of pharmaceutical composition for the treatment of cervicitis, filling a prescription is: Poria 15g, Fructus Lycii 19g, Dioscorea panthaica Prain et Burkill 8g, Herba Corydalis Bungeanae 18g, Glechota longituba (Nakai) Kupr 20g, Herba Saussureae Involueratae 20g, Flos Rosae Chinensis 40g, Herba Dendrobii 15g, Radix Dipsaci 20g, Rhizoma Ligustici 25g, Fructus Evodiae 14g.
Preparation method is: get each crude drug, mix, add 8 times of water gagings, decocts 1 hour, filter to get filtrate, to the water that adds again 5 times of amounts in medicinal residues, decoct 1 hour, filter to get filtrate, merge twice filtrate, concentrating under reduced pressure, be dried and obtain fine powder, make capsule, to obtain final product.
Clinical data:
Physical data:
Be selected in 480 examples that certain hospital accepts for medical treatment and suffer from the patient of cervicitis, and be divided at random each 240 examples of patient between treatment group and observation group sea group, observation group's patient age is in 22-46 32 years old mean age of year, it is 15.9 months that sick time reaches 9-22 the monthly average course of disease, what the patient of observation group adopted is JIEERYIN XIYE therapy for treating, in addition treatment group patient age between 22-48 year the mean age at 30 years old, sick time reaches 12-24 the monthly average course of disease 16.2 months, the patient age of last treatment group and observation group, the situation that the course of disease is general is added up between two groups of post analysis differences (p>0.05) has comparability.
Diagnostic criteria:
Tcm diagnosis is all formulated with reference to " obstetrics and gynecology " with reference to the standard of " traditional Chinese medical science disease Standardization of diagnosis and curative effect " formulation Western medicine diagnose.
Therapeutic Method:
Treatment group, when use, takes out the pharmaceutical composition of a treatment cervicitis, is dissolved in 500mL warm water, after medicine fully dissolves, rinses affected part, once a day, and a course for the treatment of each Monday.
Matched group, patient uses conventional medicine JIEERYIN XIYE (the accurate word Z10930008 of Chengdu En Wei pharmaceutical Co. Ltd traditional Chinese medicines) in the course for the treatment of of one week, take 10 milliliters of medicines and add that the boiled water of tepor mixes thoroughly to 100 milliliters, then wash pudendum and carry drug irrigation vagina depths with irrigator, once a day.
Standard curative effect:
Treatment group and the patient of observation group are carrying out observing its therapeutic effect after 3 courses for the treatment of of medication.Wherein, invalid: before and after patient, the state of an illness does not change, effective: patient's itch pain, vagina abnormal secretion thing, wherein a kind of symptom transfers to normally, effective: patient's the pain phenomenon of itching is clearly better, there is not abnormal vaginal secretions, recovery from illness: the intravaginal pain transference cure abnormal secretion thing of itching of patient also disappears.
Result:
Treatment group and the patient of observation group are after treatment, treatment group patient's overall effective percentage is 97%, recurrence rate after healing is 4.3%, the total effective rate of observation group is 78%, recurrence rate after healing is 43.3%, the cure rate for the treatment of group and relapse rate have obvious comparability (p<0.05) apparently higher than between two groups of observation groups, specifically see the following form 1.
Table 1 liang group Clinical efficacy comparison [example (%)]
Clinical model case:
Case 1, river, 29 years old, married, Laiwu City people.Patient's private prosecution: cervical erosion 3 is spent, in many ways seeks medical advice and did not thoroughly cure, bad when fashion, the aggravation of catching a cold of catching a cold today, and leucorrhea obviously increases, and have foreign odor, faint yellow purulence, and postcoital bleeding is serious, once does the year before artificial abortion.Simultaneously with symptoms such as pain in the lumbar region, the soreness of waist, urine urgency-frequencies.Be severe cervical erosion through examination in hospital, treat and do not feel any better for 3 months.2 recoveries from illness course for the treatment of of the application of the invention medicine.
Case 2, Wang, 45 years old, patient's readme: pruritus vulvae, leukorrhagia, cervical erosion, urine abnormal (not drenching), feeling of fullness in the head, dizziness, insomnia and dreamful sleep sometimes, while crying or when angry, the dizzy pain of feeling of fullness in the head, the state of an illness of seeking medical advice is not everywhere felt any better, and pudendum seriously festers, loses flesh slag, swollen pain unbearably recently, uses 3 recoveries from illness course for the treatment of of medicine of the present invention.
Case 3, Zheng, 30 years old, the frequent leukorrhagia of readme, abnormal flavour, must change underpants every day, and lower abdomen is hidden pain often, and each transfusion in menstrual period waits fails to respond to any medical treatment, and uses 3 recoveries from illness course for the treatment of of medicine of the present invention.
With clinical data, the specific embodiment of the present invention is described although above-mentioned in conjunction with the embodiments; but not limiting the scope of the invention; one of ordinary skill in the art should be understood that; on the basis of technical scheme of the present invention, those skilled in the art do not need to pay various amendments that creative work can make or distortion still in protection scope of the present invention.
Claims (7)
1. a pharmaceutical composition for the treatment of cervicitis, is characterized in that, is made up of the raw material of following weight portion proportioning: Poria 7-15 part, Fructus Lycii 10-19 part, Dioscorea panthaica Prain et Burkill 3-8 part, Herba Corydalis Bungeanae 12-18 part, Glechota longituba (Nakai) Kupr 15-20 part, Herba Saussureae Involueratae 15-20 part, Flos Rosae Chinensis 20-40 part, Herba Dendrobii 8-15 part, Radix Dipsaci 15-20 part, Rhizoma Ligustici 15-25 part, Fructus Evodiae 10-14 part.
2. the pharmaceutical composition for the treatment of cervicitis as claimed in claim 1, is characterized in that, is made up of the raw material of following weight portion proportioning: Poria 9-13 part, Fructus Lycii 15-18 part, Dioscorea panthaica Prain et Burkill 5-7 part, Herba Corydalis Bungeanae 14-17 part, Glechota longituba (Nakai) Kupr 17-19 part, Herba Saussureae Involueratae 16-18 part, Flos Rosae Chinensis 25-35 part, Herba Dendrobii 10-13 part, Radix Dipsaci 16-18 part, Rhizoma Ligustici 19-23 part, Fructus Evodiae 10-12 part.
3. the pharmaceutical composition for the treatment of cervicitis as claimed in claim 1, is characterized in that, is made up of the raw material of following weight portion proportioning: 10 parts, Poria, 15 parts of Fructus Lycii, 5 parts of Dioscorea panthaica Prain et Burkill, 15 parts of Herba Corydalis Bungeanaes, 18 parts of Glechota longituba (Nakai) Kupr, 18 parts of Herba Saussureae Involuerataes, 30 parts of Flos Rosae Chinensiss, 13 parts of Herba Dendrobiis, 18 parts of Radix Dipsacis, 20 parts of Rhizoma Ligusticis, 12 parts of Fructus Evodiaes.
4. the pharmaceutical composition for the treatment of cervicitis as claimed in claim 1, is characterized in that, is made up of the raw material of following weight portion proportioning: 12 parts, Poria, 17 parts of Fructus Lycii, 6 parts of Dioscorea panthaica Prain et Burkill, 16 parts of Herba Corydalis Bungeanaes, 18 parts of Glechota longituba (Nakai) Kupr, 17 parts of Herba Saussureae Involuerataes, 28 parts of Flos Rosae Chinensiss, 12 parts of Herba Dendrobiis, 17 parts of Radix Dipsacis, 21 parts of Rhizoma Ligusticis, 11 parts of Fructus Evodiaes.
5. the preparation method of the pharmaceutical composition of the treatment cervicitis as described in as arbitrary in claim 1-4, is characterized in that, gets each crude drug, mix, adding weight multiple is 8-10 water doubly, decocts 1-2 hour, filter to get filtrate, be the water that 4-6 doubly measures to adding again weight multiple in medicinal residues, decoct 1-1.5 hour, filter to get filtrate, merge filtrate twice, routine concentrating under reduced pressure, the dry fine powder that to obtain, make tablet or capsule, to obtain final product.
6. the using method of the pharmaceutical composition of the treatment cervicitis as described in as arbitrary in claim 1-4, is characterized in that, takes out the pharmaceutical composition of a treatment cervicitis, is dissolved in 300-800mL warm water, after medicine fully dissolves, rinses affected part, once a day.
7. the using method of the pharmaceutical composition for the treatment of cervicitis as claimed in claim 6, is characterized in that, takes out the pharmaceutical composition of a treatment cervicitis, is dissolved in 500mL warm water, after medicine fully dissolves, rinses affected part, once a day.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410195831.9A CN103920017B (en) | 2014-05-09 | 2014-05-09 | A kind of pharmaceutical composition treating cervicitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410195831.9A CN103920017B (en) | 2014-05-09 | 2014-05-09 | A kind of pharmaceutical composition treating cervicitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103920017A true CN103920017A (en) | 2014-07-16 |
| CN103920017B CN103920017B (en) | 2016-08-17 |
Family
ID=51138559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410195831.9A Expired - Fee Related CN103920017B (en) | 2014-05-09 | 2014-05-09 | A kind of pharmaceutical composition treating cervicitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103920017B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107412528A (en) * | 2017-08-08 | 2017-12-01 | 江西师范高等专科学校 | A kind of pill for treating cervicitis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1095610A (en) * | 1993-05-24 | 1994-11-30 | 潘世庆 | The pharmaceutical preparation Fubingkang of treatment, prevention gynecological diseases |
| WO2011146621A2 (en) * | 2010-05-18 | 2011-11-24 | Optimer Pharmaceuticals, Inc. | Treatment of clostridium difficile infection in patients undergoing antibiotic therapy |
-
2014
- 2014-05-09 CN CN201410195831.9A patent/CN103920017B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1095610A (en) * | 1993-05-24 | 1994-11-30 | 潘世庆 | The pharmaceutical preparation Fubingkang of treatment, prevention gynecological diseases |
| WO2011146621A2 (en) * | 2010-05-18 | 2011-11-24 | Optimer Pharmaceuticals, Inc. | Treatment of clostridium difficile infection in patients undergoing antibiotic therapy |
Non-Patent Citations (3)
| Title |
|---|
| 国家药典委员会: "《中华人民共和国药典：2010版.一部》", 31 January 2010, 中国医药科技出版社 * |
| 张兆旺等: "《中药药剂学》", 31 March 2007, 中国中医药出版社 * |
| 王砚宁等: "银草合剂治疗支原体阴道（宫颈）炎疗效观察", 《河南中医》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107412528A (en) * | 2017-08-08 | 2017-12-01 | 江西师范高等专科学校 | A kind of pill for treating cervicitis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103920017B (en) | 2016-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102743501B (en) | A kind of prescription for the treatment of qi-deficiency type uterine prolapse | |
| CN105902711A (en) | Oral administration medicament for treating hemorrhoids and application thereof | |
| CN103349766B (en) | Pharmaceutical composition for endless postpartum lochia | |
| CN102846858A (en) | Antibacterial pharmaceutical composition | |
| CN104906465A (en) | Traditional Chinese medicine blood-stasis dispersing composition for treating woman chronic pelvic inflammation and preparation method thereof | |
| CN104587127B (en) | A kind of Chinese medicine preparation for the treatment of dysfunctional uterine bleeding and preparation method thereof | |
| CN103638234B (en) | A kind of Chinese medicine composition, preparation and preparation method thereof for the treatment of tinnitus | |
| CN103908600B (en) | The external used medicine for the treatment of rheumatoid arthritis damp-heat arthralgia resistance card and preparation method | |
| CN103920017B (en) | A kind of pharmaceutical composition treating cervicitis | |
| CN102805830A (en) | Traditional Chinese medicine composite for treating acne | |
| CN104706953A (en) | Traditional Chinese medicine preparation for treating chronic cervicitis | |
| CN103272019A (en) | Traditional Chinese medicinal composition for treating wind-heat and intestine-dryness type haememorrhoids | |
| CN103845689A (en) | External application medicine for treating benign prostatic hyperplasia | |
| CN102743623B (en) | Preparation method of traditional Chinese medicine irrigation solution for treating frequent micturition and urgent micturition type trichomonas vaginitis | |
| CN102743686B (en) | The scorching clearing capsule of a kind of basin | |
| CN101366878A (en) | Traditional Chinese medicine for female acyesis and aphoria and preparation method thereof | |
| CN105125708A (en) | Pharmaceutical composition for treating rhinitis and preparation method thereof | |
| CN105920488A (en) | Traditional Chinese medicine leading-in liquid for coordinating with acusector and treating overactive bladder | |
| CN104547700B (en) | A kind of Chinese medicine composition for the treatment of preceeded menorrhea | |
| CN104800675A (en) | Medicament for treating active ulcerative colitis | |
| CN103721191A (en) | Traditional Chinese medicinal enema for treating female chronic pelvic inflammation and preparation method thereof | |
| CN104352852A (en) | Traditional Chinese medicine composition for treating insomnia due to fire excess from yin deficiency | |
| CN104707124A (en) | Traditional Chinese medicine preparation for treating chronic endometritis | |
| CN106266970B (en) | A kind of Chinese medicine composition treated production and cause endometritis | |
| CN105232971A (en) | Traditional Chinese medicine composition for treating metrorrhagia and metrostaxis with kidney yin deficiency symptom |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160817 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |